AXIM BIOTECHNOLOGIES, INC. (OTC:AXIM)
Health Care/Life Sciences • Biotechnology
CIK 1514946
Company
AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.
Address
6191 Cornerstone Court East
Suite 114
San Diego, California 92121
6191 Cornerstone Court East
Suite 114
San Diego, California 92121
Employees
7
7
Stock Info
Key Executives
Board Of Directors
President & Director Catalina Valencia |
Director Peter M O'Rourke Sr. |
Director Blake N. Schroeder |
Independent Director Timothy R. Scott |
Independent Director Robert L. Cunningham |
SEC filings
Date | Form | Event |
---|---|---|
6 Dec, 2024 | 15-12G | |
13 Nov, 2024 | NT 10-Q | |
15 Oct, 2024 | 8-K | |
15 Oct, 2024 | 4 | |
19 Aug, 2024 | 10-Q | |
13 Aug, 2024 | NT 10-Q | |
22 May, 2024 | 10-Q/A | |
20 May, 2024 | 10-Q | |
15 May, 2024 | NT 10-Q | |
16 Apr, 2024 | 10-K | |
1 Apr, 2024 | NT 10-K | |
21 Mar, 2024 | 8-K | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4 | |
19 Mar, 2024 | 4/A | |
13 Feb, 2024 | 8-K | |
28 Dec, 2023 | 8-K | |
20 Nov, 2023 | 10-Q | |
14 Nov, 2023 | NT 10-Q | |
21 Sep, 2023 | DEF 14C | |
31 Aug, 2023 | PRE 14C | |
21 Aug, 2023 | 10-Q | |
14 Aug, 2023 | NT 10-Q | |
9 Jun, 2023 | EFFECT | |
7 Jun, 2023 | UPLOAD | |
7 Jun, 2023 | CORRESP | |
2 Jun, 2023 | 8-K | |
2 Jun, 2023 | S-1 | |
30 May, 2023 | 8-K | |
30 May, 2023 | 3 | |
25 May, 2023 | 8-K | CEO Change |
22 May, 2023 | 10-Q | |
15 May, 2023 | NT 10-Q | |
17 Apr, 2023 | 10-K | |
31 Mar, 2023 | NT 10-K | |
27 Jan, 2023 | 8-K | |
15 Nov, 2022 | 10-Q/A | |
14 Nov, 2022 | 10-Q | |
7 Oct, 2022 | 144 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 3 | |
23 Sep, 2022 | 3 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | 4 | |
23 Sep, 2022 | SC 13D | |
19 Sep, 2022 | 8-K | |
31 Aug, 2022 | 3 | |
31 Aug, 2022 | 4 | |
31 Aug, 2022 | 3 | |
31 Aug, 2022 | SC 13D/A | |
31 Aug, 2022 | SC 13D | |
31 Aug, 2022 | SC 13D | |
29 Aug, 2022 | 8-K | |
26 Aug, 2022 | 4 | |
16 Aug, 2022 | 10-Q | |
16 Aug, 2022 | NT 10-Q | |
4 Aug, 2022 | EFFECT | |
2 Aug, 2022 | S-1/A | |
2 Aug, 2022 | CORRESP | |
29 Jul, 2022 | UPLOAD | |
25 Jul, 2022 | S-1 | |
14 Jun, 2022 | S-8 | |
23 May, 2022 | 10-Q | |
17 May, 2022 | NT 10-Q | |
19 Apr, 2022 | 10-K/A | |
15 Apr, 2022 | 10-K | |
31 Mar, 2022 | NT 10-K | |
9 Mar, 2022 | 8-K | |
16 Feb, 2022 | 8-K | |
15 Feb, 2022 | 4 | |
12 Jan, 2022 | 8-K | |
7 Jan, 2022 | 8-K | |
22 Nov, 2021 | 10-Q | |
15 Nov, 2021 | NT 10-Q | |
23 Aug, 2021 | 10-Q | |
16 Aug, 2021 | NT 10-Q | |
4 Aug, 2021 | 8-K | |
22 Jun, 2021 | EFFECT | |
21 Jun, 2021 | CORRESP | |
9 Jun, 2021 | S-1/A | |
2 Jun, 2021 | 10-Q/A | |
24 May, 2021 | 10-Q | |
19 May, 2021 | UPLOAD | |
14 May, 2021 | NT 10-Q | |
14 May, 2021 | 8-K | |
14 May, 2021 | S-1 | |
26 Apr, 2021 | 10-K/A | |
15 Apr, 2021 | 10-K | |
30 Mar, 2021 | NT 10-K |
Last update:2025-03-06 12:28:10.747599
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.